Andrew Ninnemann

Andrew Ninnemann holds a Master's degree in clinical psychology from the University of Maryland. Andrew is a research consultant who has served in a variety of roles helping non-profits, corporations, and academic/research institutions achieve their goals through research-driven insights. Andrew has used his foundational training as a clinical therapist and academic researcher to benefit organizations in the consulting, psychedelics, and behavioral health domains. Andrew has worn a variety of different hats - from providing therapy to patients with substance use disorders to delivering research insights to C-Suite academic and corporate audiences. Andrew's varied experience in public speaking, client engagement, and clinical research enables him to communicate research findings to non-academic audiences. At Enthea, Andrew manages the development of medical policy in the expanding field of psychedelics for the treatment of mental health, translating a growing body of research into clinical practice for patients, providers, and insurers.